. It is unfortunate that the increase in market share of neonicotinoids has coincided with unrelated increases in negative factors such as the spread of the Varroa parasitic mite, diseases, and poor bee husbandry practices. The complexity of these multiple factors make neonicotinoids an easy target for blame. Yet neonicotinoids are commonly used in Australia, a continent still free of Varroa mites and of bee problems [17] . Access of bees to natural pollen rather than protein substitutes, or honey rather than sugar or corn syrup provides bees with phytochemicals ('nutraceuticals' [13] ) that induce detoxification enzymes and immune responses. This should be kept in mind when experimentally assessing bee health.
Five of the 57 human P450 enzymes are responsible for about 95% of drug metabolism reactions. Metabolism by the highly polymorphic CYP2C19 or CYP2D6 can lead to drug levels dangerously beyond the therapeutic range. Inhibition of CYP3A4 by one drug, or by foods such as grapefruit, can lead to abnormally high levels of another drug. These enzymes are therefore actively screened during development of new pharmaceuticals to avoid such potential adverse drug reactions. One may argue [6] , and the work of Manjon et al. [4] nicely shows, how the key detoxifying bee P450s could be also screened during the process of new insecticide design and discovery to afford selective toxicity and protect bee pollinators. Innate and adaptive immunity are two complementary systems that work together to protect the host organism. A new study unravels how innate lymphoid cells and adaptive T lymphocytes act sequentially to establish microbial commensalism and ensure tissue and metabolic homeostasis.
The immune system's two arms of defence consist of innate and adaptive immunity. Most of the innate immune cells are present already before birth and are equipped with germline-encoded receptors, such as pattern recognition receptors, which allow them to readily recognise conserved pathogenassociated molecular patterns. The adaptive immune system develops in large part after birth: adaptive B and T lymphocytes are characterised by antigen-specific receptors that let them tailor their responses to an almost unlimited number of antigens. Previously, the distinction between these two arms of immunity seemed evident. However, the recent discovery of innate lymphoid cells (ILCs) challenges this strict division [1] . ILCs are considered part of the innate immune system because they do not bear a diverse repertoire of antigen-specific receptors and are already present in the tissue before birth [2] . Mature ILCs are largely tissue-resident cells [3] and are found predominantly at mucosal barrier sites [4] . [7] , Mao et al. [6] show that ILC3s are highly activated in adult mice that genetically lack T cells compared with lympho-replete wild-type mice. Activated ILC3s in these mice phosphorylate the transcription factor STAT3 and secrete interleukin-22 (IL-22). ILC3-derived IL-22 acts on IECs, which in turn engage IL-22 receptor signalling, followed by STAT3 phosphorylation (Figure 1 ). Germ-free or antibiotic-treated T-cell-deficient mice did not phosphorylate STAT3, either in ILC3s or in IECs. Consistent with previous data [8] , re-colonization of germ-free, T-celldeficient mice with segmented filamentous bacteria (SFB) re-established ILC3 and IEC activation. These findings indicate that, in the absence of T cells, SFB are sufficient to activate ILC3s.
ILC activation is controlled by a variety of signals derived from other cell types. It is known that ILC3s can respond to IL-1 family cytokines as well as to IL-23 with the production of IL-22 [9] [10] [11] . Indeed, in T-cell-deficient mice that genetically lacked IL-23 production, ILC3s did not produce IL-22. A population of CCR2-expressing monocytes and monocytederived dendritic cells were identified as a source of IL-23 (Figure 1) . Depletion of these CCR2
+ cells led to a failure to engage the ILC3-IL-22-IEC axis and express IL-22-controlled genes. These data are in line with previous work that identified different dendritic cell populations as the relevant source of IL-23, fuelling the activation of ILC3s and the production of IL-22 in the context of ulcerative colitis and during Citrobacter rodentium infection [12, 13] .
Comparing the kinetics of ILC3 activation in wild-type and T-cell-deficient mice revealed that the expansion of SFB in the small intestine between weeks 2 and 4 after birth correlated with a transient activation of the ILC3-IL-22-IEC axis. In wild-type mice, the amplitude of ILC3 activation was much lower than in mice lacking T cells. The emerging adaptive immune system silenced ILC3 activation, whilst T-cell-deficient mice showed persistent ILC3 activation. Wild-type mice were able to limit the number of SFB attaching to the intestinal epithelium, whereas the innate immune system in T-cell-deficient mice limited the length of the filaments of these bacteria. Consequently, mice that lacked both T cells and the IL-23-driven ILC3 responses were colonised with a larger number of SFB featuring long filaments [6] . These results indicate that ILC3s and T cells adopt different antimicrobial strategies, by regulating bacterial morphology or by reducing bacterial load, respectively. Transfer of T regulatory cells led to a decrease in IL-23 production by CCR2 + cells, followed by reduced ILC3
activation. Interestingly, the number of SFB remained the same. However, transfer of Th17 cells into T-cell-deficient mice reduced SFB abundance and ILC3 activation, revealing that T regulatory and Th17 cells control ILC3 activation by limiting IL-23 production and by reducing SFB numbers, respectively ( Figure 1 ). These data support previous work showing that, once a complex microbiome has formed, IL-22 production by ILC3s is suppressed via microbiotacontrolled IL-25 production [14] . In contrast, a recent study found no robust downregulation of IL-22 after weaning in T-cell-replete mice and described IL-23-producing cells that had a phenotype more consistent with intestinal macrophages than dendritic cells [15] . Future work is needed to resolve these Having established that both ILC3s and T cells contribute to regulating a commensal state, through complementary but non-redundant antimicrobial strategies, Mao et al. [6] investigated the consequences of dysregulated, prolonged ILC3 activation in T-cell-deficient mice. To this end, the authors compared the transcriptional profiles of the intestinal tissue of wild-type and T-cell-deficient mice. As expected, the continuous activation of ILC3s in T-cell-deficient mice lead to the upregulation of antimicrobial proteins downstream of STAT3. Surprisingly, genes responsible for the expression of lipid transporters in IECs were downregulated and levels of serum triglycerides were decreased in T-celldeficient mice with enhanced ILC3 activation. These mice also failed to accumulate body fat compared with the wild-type controls. Overexpression of IL-22 in wild-type mice led to a reduction in lipid transporter expression and a failure to accumulate body fat. These data indicate that prolonged activation of ILC3s leads to an imbalance in lipid processing and body fat homeostasis. Previous work has indicated important roles of ILC3-derived IL-22 for metabolism. One report found that IL-22 reduced both body weight and fat-pad mass in diet-induced and genetic models of obesity [16] . Serum triglyceride, glycerol, and free-fatty-acid levels were decreased in mice with elevated IL-22 signalling. In contrast, another study found the lymphotoxin-IL-23-IL-22 pathway to be conducive for diet-induced obesity and suggested that IL-22 and ILC3s were promoting body fat accumulation [17] . Regulating the body's metabolic demands may indeed be a unique function of ILCs.
The current paper provides an important perspective on the ongoing debate about the vestigiality of ILCs. These cells mirror Th cell subsets on the basis of their transcriptional engines, driving similar (but not identical) cellular programs. Previously, it was suggested that ILCs may be dispensable in the context of severe combined immunodeficiency in humans [5] . After hematopoietic stem cell transplantation, which reconstitutes T and B cells but not the ILC compartment, patients did not show increased susceptibility to infectious diseases compared with healthy individuals. These findings raised the proposal that ILCs were not required for protection against infections. However, transplanted patients are under continued medical surveillance and pursue a careful lifestyle, strictly avoiding sources of infection. It is possible that, in the absence of major infectious and inflammatory impact, the presence of an archaic innate line of defence is not needed. In accordance with the data from Mao et al. [6] , an important role of ILC3s in lympho-replete mice was demonstrated for rotavirus infections that occur early in life [18] . Further work considering the ontogenetic waves of effector cells may allow us to define additional unique functions of ILCs.
Mao et al. [6] identify an ontogenetic window during the neonatal period in which ILC3s form a crucial link in the IL-23-IL-22 axis of IEC activation. In the absence of T cells, ILC3s are required to establish a commensal state during microbial colonisation and to protect the intestinal epithelium early in life. The current data support the concept that SFB can activate ILC3s, which in turn control the colonization of these bacteria. However, it is unknown whether SFB are crucial for ILC3 function. Previous work showed that, while priming of Th17 cells requires tight SFB-IEC interactions, ILC3s can be triggered by non-attaching, heterologous SFB strains [8, 19] . Therefore, these bacteria may simply be a surrogate for the presence of microbiota. It remains to be seen whether specific microbial species can be identified that enhance or restrain ILC3 function. After weaning, the upcoming adaptive immune system responds to molecular cues from the microbiome and takes over the relay baton in the race against the expansion of detrimental bacterial communities. T cells employ antimicrobial strategies distinct from those of ILC3s and independent of STAT3 activation. The unique role of ILC3s in the neonatal phase and their distinct antimicrobial strategy further challenge the argument of ILC redundancy and vestigiality. The current study also highlights the strong functional interdependency of the ILC and the Th cell compartment. Although ILC3s play a unique role during a defined ontogenetic window early in life, it is crucial that the emerging T-cell system silences ILC3 immunity to maintain tissue and body fat homeostasis. It will be of great interest to investigate the signals that trigger the changes in this balanced system and allow for the reactivation of ILCs later in life.
